Television station WWOR solicited addiction expert, Dr. Cidambi’s opinion on Probuphine, an implantable form of buprenorphine, recently approved by the FDA. Probuphine is recommended for maintenance treatment of dependence on opiates. It is to be used to address opiate cravings and opiate withdrawal.

Insurance

In-network with:

Aetna
AmeriHealth
Anthem BCBS
Beacon Health Options
Emblem BCBS
GHI
Empire BCBS
Horizon BCBS (EPO, HMO, PPO)
Oscar
QualCare
United Health/Optum/Oxford
Emblem GHI*
Humana*

 

* If the QualCare logo is on the
insurance card